HDAC9 and clear cell renal carcinoma: For example, for renal clear cell carcinoma driven by UNC5D methylation, a combination protocol of “HDAC inhibitor (restoring UNC5D expression) + netrin-1 antibody” can be explored to simultaneously inhibit tumor proliferation and immune evasion.